• Luminescent ATP Cell Viability Assay Kit I for GBM

  2026-09-04

  The Luminescent ATP Cell Viability Assay Kit I enables rapid, sensitive cell viability measurement across low-to-high cell densities, making it useful for glioblastoma proliferation, drug-response, and cytotoxicity workflows. Its luciferase luminescence detection provides a practical endpoint for translating cytostatic findings into quantitative assay data while preserving the need for orthogonal mechanistic tests.

• GLI2–PRDX1 Ferroptosis Resistance in Bladder Cancer

  2026-09-04

  A 2026 Apoptosis study identifies a GLI2–PRDX1 transcriptional axis that suppresses ferroptosis and promotes bladder cancer progression. Its combination of public-data analysis, RNA sequencing, ChIP, loss-of-function, and rescue experiments supports GLI2 inhibition as a strategy for increasing sensitivity to PRDX1-targeting compounds and cisplatin.

• URB597 Workflows for Pain and FAAH Research

  2026-09-03

  URB597, also called KDS-4103, offers a selective way to raise anandamide by blocking FAAH rather than reproducing cannabidiol’s broader pharmacology. This guide translates recent inflammatory-pain findings into practical workflows for target engagement, neuroinflammation studies, behavioral phenotyping, and assay troubleshooting.

• GPR30 in Spinal CCK+ Neurons and Neuropathic Pain

  2026-09-03

  This reference study identifies GPR30 in spinal cholecystokinin-positive neurons as a cell-type-specific regulator of nerve-injury-induced pain. By combining molecular mapping, synaptic analysis, pathway manipulation, and chemogenetics, it connects spinal GPR30 signaling with AMPA-mediated sensitization and a primary somatosensory cortex-to-dorsal horn circuit.

• Trypsin BA5744 for Reliable Cell Assays

  2026-09-02

  Learn how Trypsin (SKU BA5744) can reduce workflow variability in cell viability, proliferation, differentiation, wound healing, and proteolysis studies. This scenario-based guide separates product-supported specifications from assay recommendations and highlights practical controls for reproducible interpretation.

• GW4064 for FXR Activation in Metabolic Research

  2026-09-02

  GW4064 is a selective, non-steroidal FXR agonist for connecting receptor activation with lipid metabolism, TLR4 signaling, ferroptosis, and fibrotic phenotypes. This workflow-focused guide shows how to prepare, dose, validate, and troubleshoot GW4064 in LX-2 and broader metabolic research models.

• Estradiol, GPR30, and Immune Recovery After Shock

  2026-09-01

  The reference study shows that estradiol restores splenic CD4+ T-lymphocyte proliferation and cytokine production after hemorrhagic shock by limiting endoplasmic reticulum stress through ERα and GPR30, rather than ERβ. Its pharmacological combination of receptor-selective ligands, antagonists, and an ER-stress inducer provides a useful framework for separating classical and rapid estrogen signaling in immune-trauma research.

• G-1: Selective GPR30 Agonist Workflows

  2026-09-01

  G-1 enables rapid, receptor-focused experiments spanning calcium signaling, immune dysfunction, cancer-cell migration, and cardiovascular remodeling. This workflow-led guide shows how to separate GPR30 biology from classical estrogen-receptor effects while improving dosing, controls, and assay reproducibility.

• EdU Imaging Kits (Cy5) for Cardiac Ablation Studies

  2026-08-31

  EdU Imaging Kits (Cy5) add a direct DNA-synthesis endpoint to cardiomyocyte injury models, helping distinguish reduced metabolic activity from cell-cycle arrest or cell loss after pulsed electric fields. The morphology-preserving click-chemistry workflow supports both spatial fluorescence imaging and quantitative flow cytometry.

• Gamithromycin: Mechanism, PK/PD, and Uses

  2026-08-31

  Gamithromycin, also known as ML-1709460, is a 15-membered azalide macrolide that inhibits bacterial protein synthesis at the 50S ribosomal subunit. Cattle tissue-cage data identify AUC0–24h/MIC as the principal pharmacodynamic index for Pasteurella multocida infection, while product information emphasizes lung exposure and veterinary respiratory applications.

• EdU Imaging Kits (Cy5) for PASMC Studies

  2026-08-30

  EdU Imaging Kits (Cy5) provide a morphology-preserving way to quantify S-phase entry in pulmonary artery smooth muscle cells. This guide shows how to use EdU data to interrogate the hypoxia–PUM2–KCNK3 mechanism in pulmonary hypertension without confusing proliferation with migration or apoptosis.

• Intestinal Stretch, Weight Loss, and Glucose Control

  2026-08-29

  The reference study shows that intestinal stretch is an active satiety and glucose-regulatory signal that is weakened by diet-induced obesity but restored after dietary or surgical weight loss. Its mechanistic analyses further indicate that these effects can occur independently of classical GLP-1 signaling, expanding current models of gut–brain metabolic control.

• Hypoxia and Immunometabolism in the Tumor Microenvironment

  2026-08-28

  This 2025 review unifies tumor hypoxia, metabolic reprogramming, and immune-cell dysfunction as mutually reinforcing processes that shape an immunosuppressive tumor microenvironment. Its main practical implication is that glucose availability, oxygen gradients, HIF signaling, and immune phenotypes should be analyzed together rather than as isolated variables.

• EdU Imaging Kits (Cy5) for HB Proliferation

  2026-08-28

  EdU Imaging Kits (Cy5) convert S-phase DNA synthesis into a quantitative Cy5 signal for microscopy and flow cytometry. This article translates findings from a hepatoblastoma redox study into practical assay design, controls, optimization, and troubleshooting strategies.

• Nelfinavir Mesylate: HIV-1 Protease Workflows

  2026-08-27

  Nelfinavir Mesylate supports benchmark antiviral experiments and provides a chemically tractable way to investigate DDI2–NFE2L1 control of ferroptosis. This guide connects HIV-1 protease inhibition assays with practical cell-based workflows, solvent handling, pathway readouts, and troubleshooting strategies.

7973 records 1/532 page Next 12345 下5页 Last page